Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor

Carine M. Lama; Miguel A. Hernandez-Rovira; Neha Mehta-Shah; Aaron Russell; Amy C.M. Musiek

doi:10.1016/j.jdcr.2023.06.009

Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor

Carine M. Lama, Miguel A. Hernandez-Rovira, Neha Mehta-Shah, Aaron Russell, Amy C.M. Musiek

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	64-67
Number of pages	4
Journal	JAAD Case Reports
Volume	38
DOIs	https://doi.org/10.1016/j.jdcr.2023.06.009
State	Published - Aug 2023

Keywords

Janus kinase inhibitor
Sézary syndrome
cutaneous T-cell lymphoma
mogamulizumab-associated rash

Access to Document

10.1016/j.jdcr.2023.06.009

Cite this

@article{32738eccc5d74f2d824761c5d93260d1,

title = "Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor",

keywords = "Janus kinase inhibitor, S{\'e}zary syndrome, cutaneous T-cell lymphoma, mogamulizumab-associated rash",

author = "Lama, {Carine M.} and Hernandez-Rovira, {Miguel A.} and Neha Mehta-Shah and Aaron Russell and Musiek, {Amy C.M.}",

note = "Funding Information: Funding: None.",

year = "2023",

month = aug,

doi = "10.1016/j.jdcr.2023.06.009",

language = "English",

volume = "38",

pages = "64--67",

journal = "JAAD Case Reports",

issn = "2352-5126",

}

TY - JOUR

T1 - Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor

AU - Lama, Carine M.

AU - Hernandez-Rovira, Miguel A.

AU - Mehta-Shah, Neha

AU - Russell, Aaron

AU - Musiek, Amy C.M.

N1 - Funding Information: Funding: None.

PY - 2023/8

Y1 - 2023/8

KW - Janus kinase inhibitor

KW - Sézary syndrome

KW - cutaneous T-cell lymphoma

KW - mogamulizumab-associated rash

UR - http://www.scopus.com/inward/record.url?scp=85164302309&partnerID=8YFLogxK

U2 - 10.1016/j.jdcr.2023.06.009

DO - 10.1016/j.jdcr.2023.06.009

M3 - Article

C2 - 37600742

AN - SCOPUS:85164302309

SN - 2352-5126

VL - 38

SP - 64

EP - 67

JO - JAAD Case Reports

JF - JAAD Case Reports

ER -

Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor

Keywords

Access to Document

Other files and links

Cite this